Search Results for: "Other News to Note"
-
Other News To Note
The court found that Emmaus had properly canceled all shares of its common stock held by AFH and that AFH and Heshmatpour must return to Emmaus all stock certificates representing the sharesBioWorld Today | Friday, May 17, 2013 -
Pharma: Other News To Note
The company plans to use proceeds to repurchase common stock and for general corporate purposes, including the repayment of outstanding commercial paper borrowings and upcoming debt maturitiesBioWorld Today | Friday, May 17, 2013 -
Other News To Note
Common stock in Fibrocell Science Inc., of Exton, Pa., has been approved for listing on the NYSE Market, to commence trading on May 17, under the ticker symbol FCSCBioWorld Today | Thursday, May 16, 2013 -
Other News To Note
Aastrom Biosciences Inc., of Ann Arbor, Mich., reported in an 8-K filing with the SEC that it was notified by Nasdaq that the bid price for its common stock closed below the minimum $1 per share requirement for 30 consecutive business daysBioWorld Today | Tuesday, May 14, 2013 -
Other News To Note
The split is intended to increase the per-share trading price of the common stock to satisfy the $1 minimum bid price requirement for continued listing on the Nasdaq Capital Market...Trading of the company's common stock on the Nasdaq Capital Market will continue, on a split-adjusted basis, with the opening of the markets on May 13, under new CUSIP number 69207P308BioWorld Today | Monday, May 13, 2013 -
Pharma: Other News To Note
Inc., of Whitehouse Station, N.J., said its board authorized additional purchases of up to $15 billion of Merck's common stock for its treasury...The company expects to repurchase about $7.5 billion of common stock over the next 12 months, financed through a combination of debt issuance and operating cash flows, with the remainder to be repurchased over time with no time limitBioWorld Today | Thursday, May 2, 2013 -
Other News To Note
Soligenix also will issue 1 million shares of its common stock to Intrexon, representing 8.5 percent of its outstanding shares, and provide Intrexon with the right to participate in future offerings and to purchase the company's shares in the open market...Tonix Pharmaceuticals Holdings Corp., of New York, said it effected a 1-for-20 reverse stock split, effective May 1, as a step toward its intention to list its common stock on NasdaqBioWorld Today | Thursday, May 2, 2013 -
Other News To Note
26, 2017, at an interest rate of 13 percent, and the conversion rate will be re-priced from $3.78 to $1.25 per share of common stockBioWorld Today | Tuesday, April 30, 2013 -
Other News To Note
OvaScience, of Cambridge, Mass, said its common stock was approved for listing on Nasdaq under the ticker "OVAS" and will start trading April 30BioWorld Today | Friday, April 26, 2013 -
Pharma: Other News To Note
AMC approval is one of the conditions for consummation of its tender offer for all outstanding shares of common stock in Obagi at $24 per shareBioWorld Today | Thursday, April 25, 2013 -
Other News To Note
Based upon the number of shares of Tranzyme common stock to be issued in the merger, current Tranzyme shareholders will own about 27 percent of the company, and current Ocera shareholders will own the restBioWorld Today | Thursday, April 25, 2013 -
Other News To Note
Zalicus Inc., of Cambridge, Mass., received notification from Nasdaq that the company's application to list its common stock on the Nasdaq Capital Market has been approved, and that the company's securities will be transferred from the Nasdaq Global Market at the opening of trading on April 23BioWorld Today | Monday, April 22, 2013 -
Other News To Note
The company is also reducing the number of shares of common stock from 1,5000,000,000 to 100,000,000...Upon completion, ANI stockholders will own 57 percent of the combined company's outstanding common stock, and BioSante stockholders will own 43 percentBioWorld Today | Tuesday, April 16, 2013 -
Pharma: Other News To Note
Merz Pharma Group, of Frankfurt, Germany, said it withdrew its nonbinding proposal to acquire the outstanding common stock of Obagi Medical Products Inc., of Long Beach, Calif., for $22 per share in cash...Subject to shareholder approval, at closing NovaDel will receive $400,000 in cash, 50 million shares of Suda common stock and 10 million options to purchase Suda common shares at 5 cents per shareBioWorld Today | Tuesday, April 9, 2013 -
Other News To Note
Under the agreement, the Gates Foundation will pay Anacor $17.7 million, as well as invest $5 million in Anacor common stockBioWorld Today | Tuesday, April 9, 2013 -
Other News To Note
La Jolla Pharmaceutical Co., of San Diego, said its common stock started quotation on the OTC Bulletin Board under the ticker "LJPCBioWorld Today | Thursday, April 4, 2013 -
Other News To Note
Oculus Innovative Sciences Inc., of Petaluma, Calif., disclosed a 1-for-7 reverse split of its common stock (NASDAQ:OCLS) will be effective at the open of business on April 1, 2013BioWorld Today | Monday, April 1, 2013 -
Other News To Note
Under the terms, BDSI will make an up-front payment of $2 million to Arcion in the form of unregistered shares of BDSI common stockBioWorld Today | Wednesday, March 27, 2013 -
Other News To Note
Amarantus BioScience Inc., of Sunnyvale, Calif., said the Berlin-Bremen Stock Exchange (BBSE) complied with its demand to cease unauthorized listing of its common stockBioWorld Today | Thursday, March 21, 2013 -
Other News To Note
Separately, BioSante said its board of directors declared the distribution of contingent value rights (CVRs) providing payment rights arising from a sale, transfer, license or similar transaction involving LibiGel (female testosterone gel) to holders of BioSante common stock...In the suit, In re Dendreon Corporation Class Action Litigation, an investor representing a class of individuals who purchased the company's common stock between April 29, 2010, and Aug. 3, 2011, sought unspecified damagesBioWorld Today | Tuesday, March 19, 2013
Category
Current Filters
- xcommon stock
Related Keywords
Categories
- x BioWorld Today (1832)
- x BioWorld International (79)
- x Bio Perspectives (2)
BioWorld | 3525 Piedmont Road
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Building 6, Suite 400 | Atlanta, Georgia 30305, USA
Part of Thompson Media Group LLC
Free Ezine
Sign up for Perspectives FREE e-mail newsletter.
Customer Service: In the U.S. and Canada: 1-800-477-6307
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Outside the U.S.: 1-404-262-5423
customerservice@bioworld.com
Hours: Monday - Thursday, 8:30 am - 6:00 pm EST
Friday, 8:30am - 4:30 pm EST
Copyright @ 2013 AHC Media. Reproduction, reposting content is strictly prohibited.